APO Research
Talk to an analyst

APO RESEARCH · REPORT

Loperamide Hydrochloride Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Loperamide Hydrochloride Capsules Industry Growth and Trends Forecast to 2032

23 December 202595 pages

Choose your research edition.

Industry ResearchLoperamide Hydrochloride Capsules Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Loperamide Hydrochloride Capsules Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Loperamide Hydrochloride Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Loperamide Hydrochloride Capsules Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Loperamide Hydrochloride Capsules Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Loperamide Hydrochloride Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Loperamide Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Loperamide Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Loperamide Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Loperamide Hydrochloride Capsules include Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical, Teva Pharmaceuticals, Shanghai Sine Tianping Pharmaceutical, Shanghai New Asiatic Medicine Industry Minhang, Shanghai zhaohui Pharmaceutical, Johnson & Johnson Innovative Medicine and Sinopharm Group Rongsheng Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Loperamide Hydrochloride Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Loperamide Hydrochloride Capsules market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Loperamide Hydrochloride Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Loperamide Hydrochloride Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Loperamide Hydrochloride Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Loperamide Hydrochloride Capsules Market by Company

Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical

Teva Pharmaceuticals

Shanghai Sine Tianping Pharmaceutical

Shanghai New Asiatic Medicine Industry Minhang

Shanghai zhaohui Pharmaceutical

Johnson & Johnson Innovative Medicine

Sinopharm Group Rongsheng Pharmaceutical

Loperamide Hydrochloride Capsules Segment by Type

Original Drug

Generic Drug

Loperamide Hydrochloride Capsules Segment by Application

Hospital

Clinic

Others

Loperamide Hydrochloride Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loperamide Hydrochloride Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Loperamide Hydrochloride Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loperamide Hydrochloride Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Loperamide Hydrochloride Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Loperamide Hydrochloride Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Original Drug Table 2. Major Company of Generic Drug Table 3. Global Loperamide Hydrochloride Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Loperamide Hydrochloride Capsules Sales by Type (2021-2026) & (k units) Table 5. Global Loperamide Hydrochloride Capsules Sales Market Share in Volume by Type (2021-2026) Table 6. Global Loperamide Hydrochloride Capsules Sales by Type (2021-2026) & (US$ Million) Table 7. Global Loperamide Hydrochloride Capsules Sales Market Share in Value by Type (2021-2026) Table 8. Global Loperamide Hydrochloride Capsules Price by Type (2021-2026) & (USD/unit) Table 9. Global Loperamide Hydrochloride Capsules Sales by Type (2027-2032) & (k units) Table 10. Global Loperamide Hydrochloride Capsules Sales Market Share in Volume by Type (2027-2032) Table 11. Global Loperamide Hydrochloride Capsules Sales by Type (2027-2032) & (US$ Million) Table 12. Global Loperamide Hydrochloride Capsules Sales Market Share in Value by Type (2027-2032) Table 13. Global Loperamide Hydrochloride Capsules Price by Type (2027-2032) & (USD/unit) Table 14. North America Loperamide Hydrochloride Capsules Sales by Type (2021-2026) & (k units) Table 15. North America Loperamide Hydrochloride Capsules Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Loperamide Hydrochloride Capsules Sales by Type (2021-2026) & (k units) Table 17. Europe Loperamide Hydrochloride Capsules Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Loperamide Hydrochloride Capsules Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Loperamide Hydrochloride Capsules Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Loperamide Hydrochloride Capsules Sales by Type (2021-2026) & (k units) Table 21. Latin America Loperamide Hydrochloride Capsules Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Loperamide Hydrochloride Capsules Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Loperamide Hydrochloride Capsules Sales by Type (2021-2026) & (US$ Million) Table 24. Loperamide Hydrochloride Capsules Industry Trends Table 25. Loperamide Hydrochloride Capsules Industry Drivers Table 26. Loperamide Hydrochloride Capsules Industry Opportunities and Challenges Table 27. Loperamide Hydrochloride Capsules Industry Restraints Table 28. Global Loperamide Hydrochloride Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Loperamide Hydrochloride Capsules Revenue Market Share by Company (2021-2026) Table 30. Global Loperamide Hydrochloride Capsules Sales by Company (2021-2026) & (k units) Table 31. Global Loperamide Hydrochloride Capsules Sales Share by Company (2021-2026) Table 32. Global Loperamide Hydrochloride Capsules Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Loperamide Hydrochloride Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Loperamide Hydrochloride Capsules Major Company Production Sites and Headquarters Table 35. Global Loperamide Hydrochloride Capsules Company, Product Type & Application Table 36. Global Loperamide Hydrochloride Capsules Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Loperamide Hydrochloride Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Loperamide Hydrochloride Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Loperamide Hydrochloride Capsules Sales by Region (2021-2026) & (k units) Table 41. Global Loperamide Hydrochloride Capsules Sales Market Share in Volume by Region (2021-2026) Table 42. Global Loperamide Hydrochloride Capsules Sales by Region (2021-2026) & (US$ Million) Table 43. Global Loperamide Hydrochloride Capsules Sales Market Share in Value by Region (2021-2026) Table 44. Global Loperamide Hydrochloride Capsules Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Loperamide Hydrochloride Capsules Sales by Region (2027-2032) & (k units) Table 46. Global Loperamide Hydrochloride Capsules Sales Market Share in Volume by Region (2027-2032) Table 47. Global Loperamide Hydrochloride Capsules Sales by Region (2027-2032) & (US$ Million) Table 48. Global Loperamide Hydrochloride Capsules Sales Market Share in Value by Region (2027-2032) Table 49. Global Loperamide Hydrochloride Capsules Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Loperamide Hydrochloride Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Loperamide Hydrochloride Capsules Sales by Application (2021-2026) & (k units) Table 52. Global Loperamide Hydrochloride Capsules Sales Market Share in Volume by Application (2021-2026) Table 53. Global Loperamide Hydrochloride Capsules Sales by Application (2021-2026) & (US$ Million) Table 54. Global Loperamide Hydrochloride Capsules Sales Market Share in Value by Application (2021-2026) Table 55. Global Loperamide Hydrochloride Capsules Price by Application (2021-2026) & (USD/unit) Table 56. Global Loperamide Hydrochloride Capsules Sales by Application (2027-2032) & (k units) Table 57. Global Loperamide Hydrochloride Capsules Sales Market Share in Volume by Application (2027-2032) Table 58. Global Loperamide Hydrochloride Capsules Sales by Application (2027-2032) & (US$ Million) Table 59. Global Loperamide Hydrochloride Capsules Sales Market Share in Value by Application (2027-2032) Table 60. Global Loperamide Hydrochloride Capsules Price by Application (2027-2032) & (USD/unit) Table 61. North America Loperamide Hydrochloride Capsules Sales by Application (2021-2026) & (k units) Table 62. North America Loperamide Hydrochloride Capsules Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Loperamide Hydrochloride Capsules Sales by Application (2021-2026) & (k units) Table 64. Europe Loperamide Hydrochloride Capsules Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Loperamide Hydrochloride Capsules Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Loperamide Hydrochloride Capsules Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Loperamide Hydrochloride Capsules Sales by Application (2021-2026) & (k units) Table 68. Latin America Loperamide Hydrochloride Capsules Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Loperamide Hydrochloride Capsules Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Loperamide Hydrochloride Capsules Sales by Application (2021-2026) & (US$ Million) Table 71. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Company Information Table 72. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Business Overview Table 73. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Loperamide Hydrochloride Capsules Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Loperamide Hydrochloride Capsules Product Portfolio Table 75. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Recent Development Table 76. Teva Pharmaceuticals Company Information Table 77. Teva Pharmaceuticals Business Overview Table 78. Teva Pharmaceuticals Loperamide Hydrochloride Capsules Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Teva Pharmaceuticals Loperamide Hydrochloride Capsules Product Portfolio Table 80. Teva Pharmaceuticals Recent Development Table 81. Shanghai Sine Tianping Pharmaceutical Company Information Table 82. Shanghai Sine Tianping Pharmaceutical Business Overview Table 83. Shanghai Sine Tianping Pharmaceutical Loperamide Hydrochloride Capsules Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Shanghai Sine Tianping Pharmaceutical Loperamide Hydrochloride Capsules Product Portfolio Table 85. Shanghai Sine Tianping Pharmaceutical Recent Development Table 86. Shanghai New Asiatic Medicine Industry Minhang Company Information Table 87. Shanghai New Asiatic Medicine Industry Minhang Business Overview Table 88. Shanghai New Asiatic Medicine Industry Minhang Loperamide Hydrochloride Capsules Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Shanghai New Asiatic Medicine Industry Minhang Loperamide Hydrochloride Capsules Product Portfolio Table 90. Shanghai New Asiatic Medicine Industry Minhang Recent Development Table 91. Shanghai zhaohui Pharmaceutical Company Information Table 92. Shanghai zhaohui Pharmaceutical Business Overview Table 93. Shanghai zhaohui Pharmaceutical Loperamide Hydrochloride Capsules Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Shanghai zhaohui Pharmaceutical Loperamide Hydrochloride Capsules Product Portfolio Table 95. Shanghai zhaohui Pharmaceutical Recent Development Table 96. Johnson & Johnson Innovative Medicine Company Information Table 97. Johnson & Johnson Innovative Medicine Business Overview Table 98. Johnson & Johnson Innovative Medicine Loperamide Hydrochloride Capsules Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Johnson & Johnson Innovative Medicine Loperamide Hydrochloride Capsules Product Portfolio Table 100. Johnson & Johnson Innovative Medicine Recent Development Table 101. Sinopharm Group Rongsheng Pharmaceutical Company Information Table 102. Sinopharm Group Rongsheng Pharmaceutical Business Overview Table 103. Sinopharm Group Rongsheng Pharmaceutical Loperamide Hydrochloride Capsules Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Sinopharm Group Rongsheng Pharmaceutical Loperamide Hydrochloride Capsules Product Portfolio Table 105. Sinopharm Group Rongsheng Pharmaceutical Recent Development Table 106. North America Loperamide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. North America Loperamide Hydrochloride Capsules Sales by Country (2021-2026) & (k units) Table 108. North America Loperamide Hydrochloride Capsules Sales Market Share by Country (2021-2026) Table 109. North America Loperamide Hydrochloride Capsules Sales Forecast by Country (2027-2032) & (k units) Table 110. North America Loperamide Hydrochloride Capsules Sales Market Share Forecast by Country (2027-2032) Table 111. North America Loperamide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Loperamide Hydrochloride Capsules Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Loperamide Hydrochloride Capsules Market Share by Country (2021-2026) Table 114. North America Loperamide Hydrochloride Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Loperamide Hydrochloride Capsules Market Share Forecast by Country (2027-2032) Table 116. Europe Loperamide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Europe Loperamide Hydrochloride Capsules Sales by Country (2021-2026) & (k units) Table 118. Europe Loperamide Hydrochloride Capsules Sales Market Share by Country (2021-2026) Table 119. Europe Loperamide Hydrochloride Capsules Sales Forecast by Country (2027-2032) & (k units) Table 120. Europe Loperamide Hydrochloride Capsules Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Loperamide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Loperamide Hydrochloride Capsules Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Loperamide Hydrochloride Capsules Market Share by Country (2021-2026) Table 124. Europe Loperamide Hydrochloride Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Loperamide Hydrochloride Capsules Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Loperamide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Loperamide Hydrochloride Capsules Sales by Country (2021-2026) & (k units) Table 128. Asia-Pacific Loperamide Hydrochloride Capsules Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Loperamide Hydrochloride Capsules Sales Forecast by Country (2027-2032) & (k units) Table 130. Asia-Pacific Loperamide Hydrochloride Capsules Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Loperamide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Loperamide Hydrochloride Capsules Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Loperamide Hydrochloride Capsules Market Share by Country (2021-2026) Table 134. Asia-Pacific Loperamide Hydrochloride Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Loperamide Hydrochloride Capsules Market Share Forecast by Country (2027-2032) Table 136. Latin America Loperamide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Latin America Loperamide Hydrochloride Capsules Sales by Country (2021-2026) & (k units) Table 138. Latin America Loperamide Hydrochloride Capsules Sales Market Share by Country (2021-2026) Table 139. Latin America Loperamide Hydrochloride Capsules Sales Forecast by Country (2027-2032) & (k units) Table 140. Latin America Loperamide Hydrochloride Capsules Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Loperamide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Loperamide Hydrochloride Capsules Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Loperamide Hydrochloride Capsules Market Share by Country (2021-2026) Table 144. Latin America Loperamide Hydrochloride Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Loperamide Hydrochloride Capsules Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Loperamide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Loperamide Hydrochloride Capsules Sales by Country (2021-2026) & (k units) Table 148. Middle East and Africa Loperamide Hydrochloride Capsules Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Loperamide Hydrochloride Capsules Sales Forecast by Country (2027-2032) & (k units) Table 150. Middle East and Africa Loperamide Hydrochloride Capsules Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Loperamide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Loperamide Hydrochloride Capsules Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Loperamide Hydrochloride Capsules Market Share by Country (2021-2026) Table 154. Middle East and Africa Loperamide Hydrochloride Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Loperamide Hydrochloride Capsules Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Loperamide Hydrochloride Capsules Distributors List Table 159. Loperamide Hydrochloride Capsules Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Loperamide Hydrochloride Capsules Image Figure 2. Global Loperamide Hydrochloride Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Loperamide Hydrochloride Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Loperamide Hydrochloride Capsules Sales (2021-2032) & (k units) Figure 5. Original Drug Image Figure 6. Global Original Drug Sales YoY Growth (2021-2032) & (k units) Figure 7. Generic Drug Image Figure 8. Global Generic Drug Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Loperamide Hydrochloride Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Loperamide Hydrochloride Capsules Market Share by Type 2025 VS 2032 Figure 11. North America Loperamide Hydrochloride Capsules Sales Market Share in Volume by Type in 2025 Figure 12. North America Loperamide Hydrochloride Capsules Sales Market Share in Value by Type in 2025 Figure 13. Europe Loperamide Hydrochloride Capsules Sales Market Share in Volume by Type in 2025 Figure 14. Europe Loperamide Hydrochloride Capsules Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Loperamide Hydrochloride Capsules Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Loperamide Hydrochloride Capsules Sales Market Share in Value by Type in 2025 Figure 17. Latin America Loperamide Hydrochloride Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Loperamide Hydrochloride Capsules Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Loperamide Hydrochloride Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Loperamide Hydrochloride Capsules Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Loperamide Hydrochloride Capsules Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Loperamide Hydrochloride Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Loperamide Hydrochloride Capsules Market Share by Application 2025 VS 2032 Figure 31. North America Loperamide Hydrochloride Capsules Sales Market Share in Volume by Application in 2025 Figure 32. North America Loperamide Hydrochloride Capsules Sales Market Share in Value by Application in 2025 Figure 33. Europe Loperamide Hydrochloride Capsules Sales Market Share in Volume by Application in 2025 Figure 34. Europe Loperamide Hydrochloride Capsules Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Loperamide Hydrochloride Capsules Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Loperamide Hydrochloride Capsules Sales Market Share in Value by Application in 2025 Figure 37. Latin America Loperamide Hydrochloride Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Loperamide Hydrochloride Capsules Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Loperamide Hydrochloride Capsules Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Loperamide Hydrochloride Capsules Sales Market Share in Value by Application in 2025 Figure 41. North America Loperamide Hydrochloride Capsules Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Loperamide Hydrochloride Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Loperamide Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Loperamide Hydrochloride Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Loperamide Hydrochloride Capsules Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Loperamide Hydrochloride Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Loperamide Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Loperamide Hydrochloride Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Loperamide Hydrochloride Capsules Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Loperamide Hydrochloride Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Loperamide Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Loperamide Hydrochloride Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Loperamide Hydrochloride Capsules Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Loperamide Hydrochloride Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Loperamide Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Loperamide Hydrochloride Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Loperamide Hydrochloride Capsules Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Loperamide Hydrochloride Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Loperamide Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Loperamide Hydrochloride Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Loperamide Hydrochloride Capsules Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Loperamide Hydrochloride Capsules Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical
  • Teva Pharmaceuticals
  • Shanghai Sine Tianping Pharmaceutical
  • Shanghai New Asiatic Medicine Industry Minhang
  • Shanghai zhaohui Pharmaceutical
  • Johnson & Johnson Innovative Medicine
  • Sinopharm Group Rongsheng Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Loperamide Hydrochloride Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Loperamide Hydrochloride Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Loperamide Hydrochloride Capsules Market by Type
  6. 1.3.1 Original Drug
  7. 1.3.2 Generic Drug
  8. 1.4 Global Loperamide Hydrochloride Capsules Market Size by Type
  9. 1.4.1 Global Loperamide Hydrochloride Capsules Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Loperamide Hydrochloride Capsules Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Loperamide Hydrochloride Capsules Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Loperamide Hydrochloride Capsules Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Loperamide Hydrochloride Capsules Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Loperamide Hydrochloride Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Loperamide Hydrochloride Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Loperamide Hydrochloride Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Loperamide Hydrochloride Capsules Industry Trends
  2. 2.2 Loperamide Hydrochloride Capsules Industry Drivers
  3. 2.3 Loperamide Hydrochloride Capsules Industry Opportunities and Challenges
  4. 2.4 Loperamide Hydrochloride Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Loperamide Hydrochloride Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Loperamide Hydrochloride Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Loperamide Hydrochloride Capsules Price (2021-2026)
  4. 3.4 Global Loperamide Hydrochloride Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Loperamide Hydrochloride Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Loperamide Hydrochloride Capsules Company, Product Type & Application
  7. 3.7 Global Loperamide Hydrochloride Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Loperamide Hydrochloride Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Loperamide Hydrochloride Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Loperamide Hydrochloride Capsules Tier 1, Tier 2, and Tier 3
4 Loperamide Hydrochloride Capsules Regional Status and Outlook
  1. 4.1 Global Loperamide Hydrochloride Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Loperamide Hydrochloride Capsules Historic Market Size by Region
  3. 4.2.1 Global Loperamide Hydrochloride Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Loperamide Hydrochloride Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Loperamide Hydrochloride Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Loperamide Hydrochloride Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Loperamide Hydrochloride Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Loperamide Hydrochloride Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Loperamide Hydrochloride Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Loperamide Hydrochloride Capsules by Application
  1. 5.1 Loperamide Hydrochloride Capsules Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Loperamide Hydrochloride Capsules Market Size by Application
  6. 5.2.1 Global Loperamide Hydrochloride Capsules Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Loperamide Hydrochloride Capsules Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Loperamide Hydrochloride Capsules Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Loperamide Hydrochloride Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Loperamide Hydrochloride Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Loperamide Hydrochloride Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Loperamide Hydrochloride Capsules Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Loperamide Hydrochloride Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical
  2. 6.1.1 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Company Information
  3. 6.1.2 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Business Overview
  4. 6.1.3 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Loperamide Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Loperamide Hydrochloride Capsules Product Portfolio
  6. 6.1.5 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Recent Developments
  7. 6.2 Teva Pharmaceuticals
  8. 6.2.1 Teva Pharmaceuticals Company Information
  9. 6.2.2 Teva Pharmaceuticals Business Overview
  10. 6.2.3 Teva Pharmaceuticals Loperamide Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Pharmaceuticals Loperamide Hydrochloride Capsules Product Portfolio
  12. 6.2.5 Teva Pharmaceuticals Recent Developments
  13. 6.3 Shanghai Sine Tianping Pharmaceutical
  14. 6.3.1 Shanghai Sine Tianping Pharmaceutical Company Information
  15. 6.3.2 Shanghai Sine Tianping Pharmaceutical Business Overview
  16. 6.3.3 Shanghai Sine Tianping Pharmaceutical Loperamide Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Sine Tianping Pharmaceutical Loperamide Hydrochloride Capsules Product Portfolio
  18. 6.3.5 Shanghai Sine Tianping Pharmaceutical Recent Developments
  19. 6.4 Shanghai New Asiatic Medicine Industry Minhang
  20. 6.4.1 Shanghai New Asiatic Medicine Industry Minhang Company Information
  21. 6.4.2 Shanghai New Asiatic Medicine Industry Minhang Business Overview
  22. 6.4.3 Shanghai New Asiatic Medicine Industry Minhang Loperamide Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shanghai New Asiatic Medicine Industry Minhang Loperamide Hydrochloride Capsules Product Portfolio
  24. 6.4.5 Shanghai New Asiatic Medicine Industry Minhang Recent Developments
  25. 6.5 Shanghai zhaohui Pharmaceutical
  26. 6.5.1 Shanghai zhaohui Pharmaceutical Company Information
  27. 6.5.2 Shanghai zhaohui Pharmaceutical Business Overview
  28. 6.5.3 Shanghai zhaohui Pharmaceutical Loperamide Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shanghai zhaohui Pharmaceutical Loperamide Hydrochloride Capsules Product Portfolio
  30. 6.5.5 Shanghai zhaohui Pharmaceutical Recent Developments
  31. 6.6 Johnson & Johnson Innovative Medicine
  32. 6.6.1 Johnson & Johnson Innovative Medicine Company Information
  33. 6.6.2 Johnson & Johnson Innovative Medicine Business Overview
  34. 6.6.3 Johnson & Johnson Innovative Medicine Loperamide Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Johnson & Johnson Innovative Medicine Loperamide Hydrochloride Capsules Product Portfolio
  36. 6.6.5 Johnson & Johnson Innovative Medicine Recent Developments
  37. 6.7 Sinopharm Group Rongsheng Pharmaceutical
  38. 6.7.1 Sinopharm Group Rongsheng Pharmaceutical Company Information
  39. 6.7.2 Sinopharm Group Rongsheng Pharmaceutical Business Overview
  40. 6.7.3 Sinopharm Group Rongsheng Pharmaceutical Loperamide Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sinopharm Group Rongsheng Pharmaceutical Loperamide Hydrochloride Capsules Product Portfolio
  42. 6.7.5 Sinopharm Group Rongsheng Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Loperamide Hydrochloride Capsules Sales by Country
  2. 7.1.1 North America Loperamide Hydrochloride Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Loperamide Hydrochloride Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Loperamide Hydrochloride Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Loperamide Hydrochloride Capsules Market Size by Country
  6. 7.2.1 North America Loperamide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Loperamide Hydrochloride Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Loperamide Hydrochloride Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Loperamide Hydrochloride Capsules Sales by Country
  2. 8.1.1 Europe Loperamide Hydrochloride Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Loperamide Hydrochloride Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Loperamide Hydrochloride Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Loperamide Hydrochloride Capsules Market Size by Country
  6. 8.2.1 Europe Loperamide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Loperamide Hydrochloride Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Loperamide Hydrochloride Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Loperamide Hydrochloride Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Loperamide Hydrochloride Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Loperamide Hydrochloride Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Loperamide Hydrochloride Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Loperamide Hydrochloride Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Loperamide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Loperamide Hydrochloride Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Loperamide Hydrochloride Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Loperamide Hydrochloride Capsules Sales by Country
  2. 10.1.1 South America Loperamide Hydrochloride Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Loperamide Hydrochloride Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Loperamide Hydrochloride Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Loperamide Hydrochloride Capsules Market Size by Country
  6. 10.2.1 South America Loperamide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Loperamide Hydrochloride Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Loperamide Hydrochloride Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Loperamide Hydrochloride Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Loperamide Hydrochloride Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Loperamide Hydrochloride Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Loperamide Hydrochloride Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Loperamide Hydrochloride Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Loperamide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Loperamide Hydrochloride Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Loperamide Hydrochloride Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Loperamide Hydrochloride Capsules Value Chain Analysis
  2. 12.1.1 Loperamide Hydrochloride Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Loperamide Hydrochloride Capsules Production Mode & Process
  7. 12.2 Loperamide Hydrochloride Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Loperamide Hydrochloride Capsules Distributors
  10. 12.2.3 Loperamide Hydrochloride Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst